OOIR: Observatory of International Research

Papers

(The TQCC of Periodontology 2000 is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-09-01 to 2023-09-01.)

Article	Citations
The role of the microbiota in periodontal disease	265
The role of inflammation and genetics in periodontal disease	181
Recent epidemiologic trends in periodontitis in the USA	179
Clinical and public health implications of periodontal and systemic diseases: An overview	175
Periodontitis is an inflammatory disease of oxidative stress: We should treat it that way	170
Mechanisms underlying the association between periodontitis and atherosclerotic disease	161
Current understanding of periodontal disease pathogenesis and targets for host‐modulation therapy	138
The impact of diabetes on periodontal diseases	138
The oral microbiome: Role of key organisms and complex networks in oral health and disease	127
The association of periodontal diseases with metabolic syndrome and obesity	120
Diabetes as a potential risk for periodontitis: association studies	118
The dental plaque biofilm matrix	104
Polymicrobial communities in periodontal disease: Their quasi‐organismal nature and dialogue with the host	101
Microbial signatures of health, gingivitis, and periodontitis	97
Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus	93
Periodontal therapeutics: Current host‐modulation agents and future directions	90
New developments in neutrophil biology and periodontitis	83
Oral‐lung microbiome interactions in lung diseases	78
Periodontal disease and cancer: Epidemiologic studies and possible mechanisms	76
Oral health’s inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions	70
Peri‐implantitis is not periodontitis: Scientific discoveries shed light on microbiome‐biomaterial interactions that may determine disease phenotype	70
Interconnection of periodontal disease and comorbidities: Evidence, mechanisms, and implications	69
Role of inflammasomes in the pathogenesis of periodontal disease and therapeutics	67
Periodontal diseases and adverse pregnancy outcomes: Mechanisms	67
Resilience of the oral microbiome	65

Periodontal diseases and association with atherosclerotic disease	62
Understanding resolution of inflammation in periodontal diseases: Is chronic inflammatory periodontitis a failure to resolve?	61
Periodontal disease as a possible cause for Alzheimer's disease	61
Breaking the wave of peri‐implantitis	59
Periodontal therapy and cardiovascular risk	55
Diabetes as a risk factor for periodontal disease—plausible mechanisms	54
Periodontal disease and adverse pregnancy outcomes	54
Microbial transitions from health to disease	53
A bibliometric analysis of periodontology	51
Maintaining homeostatic control of periodontal bone tissue	49
Impact of systemic factors in shaping the periodontal microbiome	49
Periodontal inflammation: Integrating genes and dysbiosis	49
Periodontitis and rheumatoid arthritis: An update 2012‐2017	48
Oral health‐related quality of life of patients rehabilitated with fixed and removable implant‐supported dental prostheses	47
Contemporary practices for mechanical oral hygiene to prevent periodontal disease	47
A bibliometric analysis of Periodontology 2000	46
Osteoporosis and periodontal diseases – An update on their association and mechanistic links	45
Association between metabolic syndrome and periodontitis: The role of lipids, inflammatory cytokines, altered host response, and the microbiome	45
Periodontitis and rheumatoid arthritis: What have we learned about their connection and their treatment?	43
A public health approach for prevention of periodontal disease	41
Microbial biogeography and ecology of the mouth and implications for periodontal diseases	41
Probiotics, including nisin‐based probiotics, improve clinical and microbial outcomes relevant to oral and systemic diseases	41
Oral biofilms revisited: A novel host tissue of bacteriological origin	41
Optimizing the quality of clinical studies on oral microbiome: A practical guide for planning, performing, and reporting	40
Acquisition and establishment of the oral microbiota	40
Herpesvirus‐bacteria synergistic interaction in periodontitis	39
Patient‐based outcomes and quality of life	37
Probiotics for periodontal health—Current molecular findings	36
The prevention of periodontal disease—An overview	36
Oral and periodontal implications of tobacco and nicotine products	34
Prevention and management of periodontal diseases and dental caries in the older adults	33
Prosthetic failures in dental implant therapy	33
Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis	30
Frailty, aging, and periodontal disease: Basic biologic considerations	30